Sickle cell disease in Middle East Arab countries

Indian Journal of Medical Research

Volumn 134, Issue 11, 2011, Pages 597-610

  El Hazmi, Mohsen A F ^a   Al Hazmi, Ali M ^b   Warsy, Arjumand S ^b  

^a Shura Council   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Malaria endemicity; Middle Eastern countries; Sickle cell anaemia; Sickle cell disease; The Arabs

Indexed keywords

BETA GLOBIN;

CLINICAL FEATURE; CONSANGUINITY; ENVIRONMENTAL FACTOR; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC DISORDER; GENETIC POLYMORPHISM; HAPLOTYPE; HBS GENE; HEREDITY; HUMAN; INHERITANCE; MIDDLE EAST; MIGRATION; NORTH AFRICA; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SICKLE CELL ANEMIA;

EID: 82155177231     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-5916.90984     Document Type: Review

References (160)

1. Gelehrter TD, Collins FS, Ginsburg D. Principles of medical genetics. London: Williams & Wilkins; 1998.
2. Alwan A, Modell B. Community control of genetic and congenital disorders. Eastern Mediterranean Region Offce Technical Publication Series 24. Alexandria. VA: World Health Organization; 1997.
3. Perutz MF. Structure of haemoglobin. Brookhaven Symp Biol 1960; 13: 165-83.
4. rd ed. Oxford: Blackwell Science Ltd.; 1981.
5. Ferrone, F, Nagel RL. Sickle hemoglobin polymerization. In: Steinberg MH, Forget BG, Higgs D, Nagel, editors. Disorders of hemoglobin: Genetics, pathophysiology, clinical management. Cambridge: Cambridge University Press; 2000.
6. Kaul DK, Fabry ME, Nagel RL. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear fow conditions: pathophysiological implications. Proc Natl Acad Sci USA 1989; 86: 3356-60.
7. Steinberg, MH, Forget, BG, Higgs, D, Nagel, M editors. Disorders of hemoglobin: Genetics, pathophysiology, clinical management. Cambridge: Cambridge University Press; 2000.
8. Caughey WS, editor. Biochemical and clinical aspects of hemoglobin abnormalities. New York: Academic Press; 1978.
9. Antonarakis SE, Orkin SH, Kazazian HH Jr, Goff SC, Boehm CD, Waber PG, et al. Evidence for multiple origins of the beta-globin gene in Southeast Asia. Proc Natl Acad Sci USA 1982; 79: 6608-11.
10. Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, et al. Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci USA 1984; 81: 1771-3.
11. Piel FB, Pati APl, Howes RE, Nyangiri OE, Gething PW, Williams TN, et al. Global distribution of the sickle cell gene and geographical confrmation of the malaria hypothesis. Nat Commun 2010; 1: 104-11.
12. Huisman THJ, Carver MFH, Efremov GD. A syllabus of human hemoglobin variants. GA, USA: The Sickle Cell Anemia Foundation in Augusta; 1996.
13. Diwani M. Erythroblastic anaemia with bone changes in Egyptian children. Possibly Cooleys anaemia. Arch Dis Child 1944; 19: 163-8.
14. Abbasy AS. Sickle cell anemia; frst case reported from Egypt. Blood 1951; 6: 555-8.
15. Lehmann H. Variations in human haemoglobin synthesis and factors governing their inheritance. Br Med Bull 1959; 15: 40-6.
16. El-Hazmi MAF, Warsy AS. Hemoglobinopathies in Arab countries. In: Teebi AS, Farag TI, editors. Genetic disorders among Arab populations. New York: Oxford University Press; 1997. p. 83-110.
17. White JM, Byrne M, Richards R, Buchanan T, Katsoulis E, Weerasingh K. Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD defciency, and alpha and beta thalassaemia. J Med Genet 1986; 23: 245-51.
18. Al-Saqladi AW, Brabin BJ, Bin-Gadeem HA, Kanhai WA, Phylipsen M, Harteveld CL. Beta-globin gene cluster haplotypes in Yemeni children with sickle cell disease. Acta Haematol 2010; 123: 182-5.
19. El-Hazmi MA, Warsy AS. Molecular studies on Yemeni sickle-cell-disease patients: Xmn I polymorphism. East Mediterr Health J 1999; 5: 1183-7.
20. El-Hazmi MA, Warsy AS. Pattern for alpha-thalassaemia in Yemeni sickle-cell-disease patients. East Mediterr Health J 1999; 5: 1159-64.
21. Lehmann H, Maranjian G, Mourant AE. Distribution of sickle-cell hemoglobin in Saudi Arabia. Nature 1963; 198: 492-3.
22. Gelpi AP. Glucose-6-phosphate dehydrogenase defciency, the sickling trait, and malaria in Saudi Arab children. J Pediatr 1967; 71: 138-46.
23. El-Hazmi MA. On the nature of sickle-cell disease in the Arabian Peninsula. Hum Genet 1979; 52: 323-35.
24. El-Hazmi MA, Lehmann H. Human haemoglobins and haemoglobinopathies in Arabia: Hb O Arab in Saudi Arabia. Acta Haematol 1980; 63: 268-73.
25. El-Hazmi MA. Haemoglobin disorders: a pattern for thalassaemia and haemoglobinopathies in Arabia. Acta Haematol 1982; 68: 43-51.
26. El -Hazmi MA, Warsy AS, Al-Swailem AR, Al-Swailem AM, Bahakim HM. Sickle cell gene in the population of Saudi Arabia. Hemoglobin 1996; 20: 187-98.
27. El-Hazmi MA, Warsy AS. Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Health J 1999; 5: 1147-53.
28. El-Hazmi MA. Haemoglobinopathies, thalassaemias and enzymopathies in Saudi Arabia: the present status. Acta Haematol 1987; 78: 130-4.
29. Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Al-Omar AA. The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J 2008; 29: 1480-3.
30. Blair D, Gregory WB. Nutritional vs hereditary anaemias appropriate screening procedures for Bahrain. Bahrain Med Bull 1986; 8: 124-7.
31. El-Shafei AM, Rao PS, Sandhu AK. Pregnancy and sickle cell hemoglobinopathies in Bahrain. Saudi Med J 1988; 3: 283-8.
32. Buhazza MA, Bikhazi AB, Khouri FP. Evaluation of haematological fndings in 50 Bahraini patients with sickle cell disease and in some of their parents. J Med Genet 1985; 22: 293-5.
33. Al Arrayed SS, Haites N. Features of sickle-cell disease in Bahrain. East Mediterr Health J 1995; 1: 112-9.
34. Al-Arrayed S, Hafadh N, Amin S, Al-Mukhareq H, Sanad H. Student screening for inherited blood disorders in Bahrain. East Mediterr Health J 2003; 9: 344-52.
35. Al-Arrayed SS. Beta globin gene haplotypes in Bahraini patients with sickle cell anaemia. Bahrain Med Bull 1995; 17: 15-20.
36. Dash S. Hemoglobin S-D disease in a Bahraini child. Bahrain Med Bull 1995; 17: 154-5.
37. Mohammad AM, Ardatl KO, Bajakian KM. Sickle cell disease in Bahrain: coexistence and interaction with glucose-6-phosphate dehydrogenase (G6PD) defciency. J Trop Pediatr 1998; 44: 70-2.
38. Bakioglu I, Hattori Y, Kutlar A, Mathew C, Huisman TH. Five adults with mild sickle cell anemia share a beta S chromosome with the same haplotype. Am J Hematol 1985; 20: 297-300.
39. Fawzi ZO, Al-Hilali A, Fakhroo N, Al-Bin-Ali A, Al-Mansour S. Distribution of hemoglobinopathies and thalassemias in Qatari nationals seen at Hamad hospital in Qatar. Qatar Med J 2003; 12: 20-4.
40. Ali SA. Milder variant of sickle-cell disease in Arabs in Kuwait associated with unusually high level of foetal haemoglobin. Br J Haematol 1970; 19: 613-9.
41. Adekile AD, Gu LH, Baysal E, Haider MZ, al-Fuzae L, Aboobacker KC, et al. Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles and beta S haplotypes among Kuwaiti Arabs. Acta Haematol 1994; 92: 176-81.
42. Adekile AD, Haider MZ, Morbidity, beta S haplotype and alpha-globin gene patterns among sickle cell anemia patients in Kuwait. Acta Haematol 1996; 96: 150-4.
43. Marouf R, D'souza TM, Adekile AD. Hemoglobin electrophoresis and hemoglobinopathies in Kuwait. Med Princ Pract 2002; 11: 38-41.
44. Kamel K. Sickle cell hemoglobin: origin and clinical manifestations in Arabs and relation to fetal hemoglobin levels. Qatar Med J 1984; 5: 23-6.
45. Miller CJ, Dunn EV, Berg B, Abdouni SF. A hematological survey of preschool children of the United Arab Emirates. Saudi Med J 2003; 24: 609-13.
46. Al Hosani H, Salah M, Osman HM, Farag HM, Anvery SM. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates. East Mediterr Health J 2005; 11: 300-7.
47. Awaad MO, Bayoumi R. Sickle cell disease in adult Bedouins of Al-Ain district, United Arab Emirates. Emirates Med J 1993; 11: 21-4.
48. El-Kalla S, Baysal E. Genotype-phenotype correlation of sickle cell disease in the United Arab Emirates. Pediatr Hematol Oncol 1998; 15: 237-42.
49. Miller CJ, Dunn EV, Berg B, Abdouni SF. A hematological survey of preschool children of the United Arab Emirates. Saudi Med J 2003; 24: 609-13.
50. Baysal E. Hemoglobinopathies in the United Arab Emirates. Hemoglobin 2001; 25: 247-53.
51. Nagel RL, Daar S, Romero JR, Suzuka SM, Gravell D, Bouhassira E, et al. HbS-oman heterozygote: a new dominant sickle syndrome. Blood 1998; 92: 4375-82.
52. Suresh V, Asila NS, Nafsa MZ, Laitha MN, Susamma M. Haemoglobin S Oman trait- A sickling variant. Oman Med J 1999; 16: 23-4.
53. Al Jahdhamy R, Makki H, Farrell G, Al Azzawi S. A case of compound heterozygosity for Hb S and Hb S Oman. Br J Haematol 2002; 116: 504.
54. Rajab AG, Patton MA, Modell B. Study of hemoglobinopathies in Oman through a national register. Saudi Med J 2000; 21: 1168-72.
55. Al-Riyami AA, Suleiman AJ, Aff M, Al-Lamki ZM, Daar S. A community-based study of common hereditary blood disorders in Oman. East Mediterr Health J 2001; 7: 1004-11.
56. Daar S, Hussain HM, Gravell D, Nagel RL, Krishnamoorthy R. Genetic epidemiology of HbS in Oman: multicentric origin for the betaS gene. Am J Hematol 2000; 64: 39-46.
57. Fathalla M. Unusual age of presentation of hand-foot syndrome. Emirates Med J 1986; 4: 143-5.
58. El-Latif MA, Filon D, Rund D, Oppenheim A, Kanaan M. The beta+-IVS-I-6 (T-->C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin 2002; 26: 33-40.
59. Samarah F, Ayesh S, Athanasiou M, Christakis J, Vavatsi N. beta(S)-Globin gene cluster haplotypes in the West Bank of Palestine. Hemoglobin 2009; 33: 143-9.
60. Darwish HM, El-Khatib FF, Ayesh Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine. Hemoglobin 2005; 29: 119-32.
61. Kyriacou K, Al Quobaili F, Pavlou E, Christopoulos G, Ioannou P, Kleanthous M. Molecular characterization of beta-thalassemia in Syria. Hemoglobin 2000; 24: 1-13.
62. El-Hazmi MAF, Warsy AS, Bashir N, Beshlawi A, Hussain IR, Temtamy S, et al. Haplotypes of the beta-globin gene as prognostic factors in sickle-cell disease. East Mediterr Health J 1999; 5: 1154-8.
63. Khutsishvili GE. Current concepts on the structure of normal and pathologic hemoglobins (review of the literature). Lab Delo 1971; 8: 454-6.
64. Alkasab FM, Al-Alusi FA, Adnani MS, Alkafajei AM, Al-Shakerchi NH, Noori SF. The prevalence of sickle cell disease in Abu-AL-Khasib district of southern Iraq. J Trop Med Hyg 1981; 84: 77-80.
65. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase defciency in Basra. East Mediterr Health J 2003; 9: 45-54.
66. Mansour AA. Infuence of sickle hemoglobinopathy on growth and development of young adult males in Southern Iraq. Saudi Med J 2003; 24: 544-6.
67. Al-Allawi NA, Al-Dousky AA. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme. East Mediterr Health J 2010; 16: 381-5.
68. Bashir N, Barkawi M, Sharif L. Prevalence of haemoglobinopathies in school children in Jordan Valley. Ann Trop Paediatr 1991; 11: 373-6.
69. Bashir N, Barkawi M, Sharif L. Sickle cell/beta-thalassemia in North Jordan. J Trop Pediatr 1992; 38: 196-8.
70. Sunna EI, Gharaibeh NS, Knapp DD, Bashir NA. Prevalence of hemoglobin S and beta-thalassemia in northern Jordan. J Obstet Gynaecol Res 1996; 22: 17-20.
71. Talafh K, Hunaiti AA, Gharaibeh N, Gharaibeh M, Jaradat S. The prevalence of hemoglobin S and glucose-6-phosphate dehydrogenase defciency in Jordanian newborn. J Obstet Gynaecol Res 1996; 22: 417-20.
72. al-Sheyyab M, Rimawi H, Izzat M, Batieha A, el Bashir N, Almasri N, et al. Sickle cell anaemia in Jordan and its clinical patterns. Ann Trop Paediatr 1996; 16: 249-53.
73. Dabbous IA, Firzli SS. Sickle cell anemia in Lebanon - its predominance in the Mohammedans. Z Morphol Anthropol 1968; 59: 225-31.
74. Inati A, Jradi O, Tarabay H, Moallem H, Rachkidi Y, El Accaoui R, et al. Sickle cell disease: the Lebanese experience. Int J Lab Hematol 2007; 29: 399-408.
75. Inati A, Taher A, Bou Alawi W, Koussa S, Kaspar H, Shbaklo H, et al. Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol 2003; 70: 79-83.
76. Abboud MR, Musallam KM. Sickle cell disease at the dawn of the molecular era. Hemoglobin 2009; 33 (Suppl 1): S93-S106.
77. Abbott PH. The sickle cell trait among the Zande tribe of the southern Sudan. East Afr Med J 1950; 27: 162-3.
78. Foy H, Kondi A, Timms GL, Brass W, Bishra F. The variability of sickle-cell rates in the tribes of Kenya and the Southern Sudan. Br Med J 1954; 1: 294-7.
79. Ibrahim SA. Sickle-cell thalassaemia disease in Sudanese. East Afr Med J 1970; 47: 47-9.
80. Omer A, Ali M, Omer AH, Mustafa MD, Satir AA, Samuel AP. Incidence of G-6-PD defciency and abnormal haemoglobins in the indigenous and immigrant tribes of the Sudan. Trop Geogr Med 1972; 24: 401-5.
81. Fleming AF, Storey J, Molineaux L, Iroko EA, Attai ED. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 1979; 73: 161-72.
82. Bayoumi RA, Abu Zeid YA, Abdul Sadig A, Awad Elkarim O. Sickle cell disease in Sudan. Trans R Soc Trop Med Hyg 1988; 82: 164-8.
83. Mohamed AO, Bayoumi RA, Hofvander Y, Omer MI, Ronquist G. Sickle cell anaemia in Sudan: clinical fndings, haematological and serum variables. Ann Trop Paediatr 1992; 12: 131-6.
84. Mohamed AO. Sickle cell disease in the Sudan. Clinical and biochemical aspects. Minireview based on a doctoral thesis. Ups J Med Sci 1992; 97: 201-28.
85. Mohammed AO, Attalla B, Bashir FM, Ahmed FE, El Hassan AM, Ibnauf G, et al. Relationship of the sickle cell gene to the ethnic and geographic groups populating the Sudan. Community Genet 2006; 9: 113-20.
86. Marin A, Cerutti N, Massa ER. Use of the amplifcation refractory mutation system (ARMS) in the study of HbS in predynastic Egyptian remains. Boll Soc Ital Biol Sper 1999; 75: 27-30.
87. Pays JF. Tutankhamun and sickle-cell anaemia. Bull Soc Pathol Exot 2010; 103: 346-7.
88. Abbasy AS. Sickle cell anemia; frst case reported from Egypt. Blood 1951; 6: 555-8.
89. Awny AY, Kamel K, Hoerman KC. ABO blood groups and hemoglobin variants among Nubians, Egypt, U.A.R. Am J Phys Anthropol 1965; 23: 81-2.
90. El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin 2009; 33 (Suppl 1): S14-20.
91. Soliman AT, elZalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr 1999; 45: 23-30.
92. Juillan M. Survey on the incidence of sickle-shaped erythrocytes in Algeria. Arch Inst Pasteur Alger 1961; 39: 261-70.
93. Trabuchet G, Dahmane M, Benabadji M. Abnormal hemoglobins in Algeria. Sem Hop 1977; 53: 879-81.
94. Dahmane-Arbane M, Blouquit Y, Arous N, Bardakdjian J, Benamani M, Riou J, et al. [Hemoglobin Boumerdès alpha 2(37) (C2) Pro----Arg beta 2: a new variant of the alpha chain associated with hemoglobin S in an Algerian family]. Nouv Rev Fr Hematol 1987; 29: 317-20.
95. Labie D, Pagnier J, Lapoumeroulie C, Rouabhi F, Dunda-Belkhodja O, Chardin P, et al. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci USA 1985; 82: 2111-4.
96. Pagnier J, Dunda-Belkhodja O, Zohoun I, Teyssier J, Baya H, Jaeger G, et al. alpha-Thalassemia among sickle cell anemia patients in various African populations. Hum Genet 1984; 68: 318-9.
97. Haj Khelil A, Denden S, Leban N, Daimi H, Lakhdhar R, Lefranc G, et al. Hemoglobinopathies in North Africa: a review. Hemoglobin 2010; 34: 1-23.
98. Trabuchet G, Pagnier J, Benabadji M, Labie D. Homozygous cases for hemoglobin J Mexico (alpha54 (E3)Gln replaced by Glu) evidence for a duplicated alpha gene with unequal expression. Hemoglobin 1976-1977; 1: 13-25.
99. Ben Rachid MS, Farhat M, Brumpt LC. Hemoglobin S disease in Tunisia. Apropos of a familial case with a study of the family tree]. Nouv Rev Fr Hematol 1967; 7: 393-400.
100. Mseddi S, Gargouri J, Labiadh Z, Kassis M, Elloumi M, Ghali L, et al. Prevalence of hemoglobin abnormalities in Kebili (Tunisian South)]. Rev Epidemiol Sante Publique 1999; 47: 29-36.
101. Frikha M, Fakhfakh F, Mseddi S, Gargouri J, Ghali L, Labiadh Z, et al. Hemoglobin beta S haplotype in the Kebili region (southern Tunisia)]. Transfus Clin Biol 1998; 5: 166-72.
102. Znaidi R, Hafsia R, Megid M, M'Rad A, Kastally R, Hafsia A. [Hemoglobinopathies in Nefza: a model of health intervention]. Tunis Med 1996; 74: 33-8.
103. Chebil-Laradi S, Pousse H, Khelif A, Ghanem N, Martin J, Kortas M, et al. Screening of hemoglobinopathies and molecular analysis of beta-thalassemia in Central Tunisia. Arch Pediatr 1994; 1: 1100-5.
104. Haj Khelil A, Laradi S, Miled A, Omar Tadmouri G, Ben Chibani J, Perrin P. Clinical and molecular aspects of haemoglobinopathies in Tunisia. Clin Chim Acta 2004; 340: 127-37.
105. Fattoum S. Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data. Tunis Med 2006; 84: 687-96.
106. Fattoum S, Guemira F, Oner C, Oner R, Li HW, Kutlar F, Huisman TH. Beta-thalassemia, HB S-beta-thalassemia and sickle cell anemia among Tunisians. Hemoglobin 1991; 15: 11-21.
107. Mellouli F, Bejaoui M. The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases. Arch Pediatr 2008; 15: 24-8.
108. Abbes S, Fattoum S, Vidaud M, Goossens M, Rosa J. Sickle cell anemia in the Tunisian population: haplotyping and HbF expression. Hemoglobin 1991; 15: 1-9.
109. Molchanova TP, Wilson JB, Gu LH, Guemira F, Fattoum S, Huisman TH. Hb Bab-Saadoun or alpha 2 beta (2)48(CD7) Leu----Pro, a mildly unstable variant found in an Arabian boy from Tunisia. Hemoglobin 1992; 16: 267-73.
110. Jain RC. Haemoglobinopathies in Libya. J Trop Med Hyg 1979; 82: 128-32.
111. Jain RC. Sickle cell and thalassaemic genes in Libya. Trans R Soc Trop Med Hyg 1985; 79: 132-3.
112. Radhakrishnan K, Thacker AK, Maloo JC, el-Mangoush MA. Sickle cell trait and stroke in the young adult. Postgrad Med J 1990; 66: 1078-80.
113. el Mauhoub M, el Bargathy S, Sabharwal HS, Aggarwal VP, el Warrad K. Priapism in sickle cell anaemia: a case report. Ann Trop Paediatr 1991; 1: 371-2.
114. st ed. Cairo: National Publishing House; 1967.
115. Khlat M, Khudr A. Cousin marriages in Beirut, Lebanon: is the pattern changing? J Biosoc Sci 1984; 16: 369-73.
116. Al-Roshoud R, Farid S. Kuwait Health Survey. Kuwait: Ministry of Health Publication; 1991.
117. Panter-Brick C. Parental responses to consanguinity and genetic disease in Saudi Arabia. Soc Sci Med 1991; 33: 1295-302.
118. Basson PM. Genetic disease and culture patterns in Lebanon. J Biosoc Sci 1979; 11: 201-7.
119. Khlat H. Endogamy in the Arab World. In: Teebi AS, Faraj TI, editors. Genetic disorders among Arab population. New York: Oxford University Press; 1997. p. 63-80.
120. Jaber L, Bailey-Wilson JE, Haj-Yehia M, Hernandez J, Shohat M. Consanguineous matings in an Israeli-Arab community. Arch Pediatr Adolesc Med 1994: 148: 412-5.
121. Livingstone FB. Sickling and malaria. Br Med J 1957; 1: 762-3.
122. El-Hazmi MA, Warsy AS. On the nature of sickle cell disease in the south-western province of Saudi Arabia. Acta Haematol 1986; 76: 212-6.
123. El-Hazmi MA. Clinical and haematological diversity of sickle cell disease in Saudi children. J Trop Pediatr 1992; 38: 106-12.
124. El-Hazmi MA, Warsy AS. The frequency of glucose-6-phosphate dehydrogenase phenotypes and sickle cell genes in Al-Qatif oasis. Ann Saudi Med 1994; 14: 491-4.
125. El-Hazmi MA, Warsy AS, Bahakim HH, al-Swailem A. Glucose-6-phosphate dehydrogenase defciency and the sickle cell gene in Makkah, Saudi Arabia. J Trop Pediatr 1994; 40: 12-6.
126. Deeb ME, Sayegh LG. Population dimensions in the Arab world. In: Teebi AS, Faraj TI, editors. Genetic disorders among Arab population. New York: Oxford University Press; 1997. p. 29.
127. Trabuchet G, Benabadji M, Labie D. Genetic and biosynthetic studies of families carrying hemoglobin J alpha Mexico: association of alpha-thalassemia with HbJ. Hum Genet 1978; 42: 189-99.
128. Baghernajad-Salehi L, D'Apice MR, Babameto-Laku A, Biancolella M, Mitre A, Russo S, et al. Pilot beta-thalassaemia screening program in the Albanian population for a health planning program. Acta Haematol 2009; 121: 234-8.
129. Weatherall DJ, Clegg JB, Blankson J, McNeil JR. A new sickling disorder resulting from interaction of the genes for haemoglobin S and alpha-thalassaemia. Br J Haematol 1969; 17: 517-26.
130. Gelpi AP. Sickle cell disease in Saudi Arabs. Acta Haematol 1970; 43: 89-99.
131. Pembrey ME, Weatherall DJ, Clegg JB, Bunch C, Perrine RP. Haemoglobin Bart's in Saudi Arabia. Br J Haematol 1975; 29: 221-34.
132. Pembrey ME, Wood WG, Weatherall DJ, Perrine RP. Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia. Br J Haematol 1978; 40: 415-29.
133. Perrine RP, Brown MJ, Clegg JB, Weatherall DJ, May A. Benign sickle-cell anaemia. Lancet 1972; 2: 1163-7.
134. El-Hazmi MA, Bahakim HM, al-Swailem AM, Warsy AS. The features of sickle cell disease in Saudi children. J Trop Pediatr 1990; 36: 148-55.
135. El-Hazmi MA, Warsy AS. A comparative study of haematological parameters in children suffering from sickle cell anaemia (SCA) from different regions of Saudi Arabia. J Trop Pediatr 2001; 47: 136-41.
136. El-Hazmi MA. Clinical and haematological diversity of sickle cell disease in Saudi children. J Trop Pediatr 1992; 38: 106-12.
137. El-Hazmi MA. Heterogeneity and variation of clinical and haematological expression of haemoglobin S in Saudi Arabs. Acta Haematol 1992; 88: 67-71.
138. Powars DR. Sickle cell anemia: beta S-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol 1991; 28: 202-8.
139. El-Hazmi MA, Bahakim HM, Warsy AS. DNA polymorphism in the beta-globin gene cluster in Saudi Arabs: relation to severity of sickle cell anaemia. Acta Haematol 1992; 88: 61-6.
140. El-Hazmi MA. Beta-globin gene polymorphism in the Saudi Arab population. Hum Genet 1986; 73: 31-4.
141. El-Hazmi MA, Warsy AS. On the molecular interactions between alpha-thalassaemia and sickle cell gene. J Trop Pediatr 1993; 39: 209-13.
142. El-Hazmi MA. Xmn I polymorphism in the gamma-globin gene region among Saudis. Hum Hered 1989; 39: 12-9.
143. El-Hazmi MA, Bahakim HM, Warsy AS, al-Momen A, al-Wazzan A, al-Fawwaz I, et al. Does G gamma/A gamma ratio and Hb F level infuence the severity of sickle cell anaemia. Mol Cell Biochem 1993; 124: 17-22.
144. El-Hazmi MA, al-Swailem AR, Bahakim HM, al-Faleh FZ, Warsy AS. Effect of alpha thalassaemia, G-6-PD defciency and Hb F on the nature of sickle cell anaemia in south-western Saudi Arabia. Trop Geogr Med 1990; 42: 241-7.
145. El-Hazmi MA. Clinical manifestation and laboratory fndings of sickle cell anaemia in association with alpha-thalassaemia in Saudi Arabia. Acta Haematol 1985; 74: 155-60.
146. El-Hazmi MA, Warsy AS, Addar MH, Babae Z. Fetal haemoglobin level - effect of gender, age and haemoglobin disorders. Mol Cell Biochem 1994; 135: 181-6.
147. Taha HM, Rehmani RS. Pain management of children and adolescents with sickle cell disease presenting to the emergency department. Saudi Med J 2011; 32: 152-5.
148. Rehmani RS. Pain practices in a Saudi emergency department. Saudi Med J 2010; 31: 539-44.
149. Machado NO, Grant CS, Alkindi S, Daar S, Al-Kindy N, Al Lamki Z, et al. Splenectomy for haematological disorders: a single center study in 150 patients from Oman. Int J Surg 2009; 7: 476-81.
150. El-Hazmi MA, al-Momen A, Warsy AS, Kandaswamy S, Huraib S, Harakati M, et al. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin. Acta Haematol 1995; 93: 57-61.
151. El-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, et al. On the use of hydroxyurea/ erythropoietin combination therapy for sickle cell disease. Acta Haematol 1995; 94: 128-34.
152. El-Hazmi MA, Warsy AS, al-Momen A, Harakati M. Hydroxyurea for the treatment of sickle cell disease. Acta Haematol 1992; 88: 170-4.
153. El-Hazmi MA, Warsy AS, al-Fawaz I, Opawoye AO, Taleb HA, Howsawi Z, et al. Piracetam is useful in the treatment of children with sickle cell disease. Acta Haematol 1996; 96: 221-6.
154. Al Arrayed S, Al Hajeri A. Public awareness of sickle cell disease in Bahrain. Ann Saudi Med 2010; 30: 284-8.
155. Al Arrayed S. Campaign to control genetic blood diseases in Bahrain. Community Genet 2005; 8: 52-5.
156. Al-Allawi NA, Al-Dousky AA. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme. East Mediterr Health J 2010; 16: 381-5.
157. Al Sulaiman A, Saeedi M, Al Suliman A, Owaidah T. Postmarital follow-up survey on high risk patients subjected to premarital screening program in Saudi Arabia. Prenat Diagn 2010; 30: 478-81.
158. Al-Shahrani M. Steps toward the prevention of hemoglobinopathies in the kingdom of Saudi Arabia. Hemoglobin 2009; 33 (Suppl 1): S21-4.
159. El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin 2009; 33 (Suppl 1): S14-20.
160. El-Hazmi MA. Spectrum of genetic disorders and the impact on health care delivery: an introduction. East Mediterr Health J 1999; 5: 1104-13.